Stessman Holly A F, Willemsen Marjolein H, Fenckova Michaela, Penn Osnat, Hoischen Alexander, Xiong Bo, Wang Tianyun, Hoekzema Kendra, Vives Laura, Vogel Ida, Brunner Han G, van der Burgt Ineke, Ockeloen Charlotte W, Schuurs-Hoeijmakers Janneke H, Klein Wassink-Ruiter Jolien S, Stumpel Connie, Stevens Servi J C, Vles Hans S, Marcelis Carlo M, van Bokhoven Hans, Cantagrel Vincent, Colleaux Laurence, Nicouleau Michael, Lyonnet Stanislas, Bernier Raphael A, Gerdts Jennifer, Coe Bradley P, Romano Corrado, Alberti Antonino, Grillo Lucia, Scuderi Carmela, Nordenskjöld Magnus, Kvarnung Malin, Guo Hui, Xia Kun, Piton Amélie, Gerard Bénédicte, Genevieve David, Delobel Bruno, Lehalle Daphne, Perrin Laurence, Prieur Fabienne, Thevenon Julien, Gecz Jozef, Shaw Marie, Pfundt Rolph, Keren Boris, Jacquette Aurelia, Schenck Annette, Eichler Evan E, Kleefstra Tjitske
Department of Genome Sciences, University of Washington, Seattle, WA 98105, USA.
Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Am J Hum Genet. 2016 Mar 3;98(3):541-552. doi: 10.1016/j.ajhg.2016.02.004.
Intellectual disability (ID) and autism spectrum disorders (ASD) are genetically heterogeneous, and a significant number of genes have been associated with both conditions. A few mutations in POGZ have been reported in recent exome studies; however, these studies do not provide detailed clinical information. We collected the clinical and molecular data of 25 individuals with disruptive mutations in POGZ by diagnostic whole-exome, whole-genome, or targeted sequencing of 5,223 individuals with neurodevelopmental disorders (ID primarily) or by targeted resequencing of this locus in 12,041 individuals with ASD and/or ID. The rarity of disruptive mutations among unaffected individuals (2/49,401) highlights the significance (p = 4.19 × 10(-13); odds ratio = 35.8) and penetrance (65.9%) of this genetic subtype with respect to ASD and ID. By studying the entire cohort, we defined common phenotypic features of POGZ individuals, including variable levels of developmental delay (DD) and more severe speech and language delay in comparison to the severity of motor delay and coordination issues. We also identified significant associations with vision problems, microcephaly, hyperactivity, a tendency to obesity, and feeding difficulties. Some features might be explained by the high expression of POGZ, particularly in the cerebellum and pituitary, early in fetal brain development. We conducted parallel studies in Drosophila by inducing conditional knockdown of the POGZ ortholog row, further confirming that dosage of POGZ, specifically in neurons, is essential for normal learning in a habituation paradigm. Combined, the data underscore the pathogenicity of loss-of-function mutations in POGZ and define a POGZ-related phenotype enriched in specific features.
智力障碍(ID)和自闭症谱系障碍(ASD)具有遗传异质性,并且有大量基因与这两种疾病相关。最近的外显子组研究报道了POGZ中的一些突变;然而,这些研究并未提供详细的临床信息。我们通过对5223例神经发育障碍(主要是ID)患者进行诊断性全外显子组、全基因组或靶向测序,或对12041例ASD和/或ID患者进行该基因座的靶向重测序,收集了25例POGZ基因破坏性突变患者的临床和分子数据。未受影响个体中破坏性突变的罕见性(2/49401)凸显了这种遗传亚型相对于ASD和ID的重要性(p = 4.19×10⁻¹³;优势比 = 35.8)和外显率(65.9%)。通过对整个队列的研究,我们定义了POGZ患者的常见表型特征,包括不同程度的发育迟缓(DD),与运动迟缓及协调问题的严重程度相比,言语和语言迟缓更为严重。我们还发现了与视力问题、小头畸形、多动、肥胖倾向和喂养困难之间的显著关联。胎儿脑发育早期POGZ的高表达,特别是在小脑和垂体中的高表达,可能解释了其中一些特征。我们在果蝇中进行了平行研究,通过诱导条件性敲低POGZ的直系同源基因row,进一步证实POGZ的剂量,特别是在神经元中的剂量,对于习惯化范式中的正常学习至关重要。综合来看,这些数据强调了POGZ功能丧失突变的致病性,并定义了一种富含特定特征的POGZ相关表型。